Sunpasitthiprasong Hospital
Ubonratchathani 34000
1 studies enrolling now · 2 studies all time
What they study most
Cardiovascular Risk, Chronic Kidney Disease, Inflammation, Moderately to Severely Active Ulcerative Colitis
Studies at this site
- A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis — Recruiting now
- ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation — Completed